Released Feb 24, 2015, before the open
10-K filed Mar 12, 2015, 71 days after period end · 0001144204-15-015700
Q4 2014 · 10-K
derived · Computed from the longer spans the company filed.
Revenue—
Net Income-$6.23M-$6.23M derivedN/M vs Q4 2013N/M vs Q3 2014
EPS, diluted—Not derived. Share counts vary by quarter.
Operating Incomederived-$6,284,717N/M
Operating Cash Flowderived-$3,592,920—
Free Cash Flowderived-$3,722,357N/M
What the release said
The release
Same quarter
| Metric | Q4 2014dderived from reported figures | Q4 2013dderived from reported figures | Q4 2012 | Q4 2011 |
|---|---|---|---|---|
| Net Income | -$6.23M | -$6.05M | -$3.79M | -$18.86M |
| EPS Diluted | — | — | -$0.29 | -$1.52 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Assembly Biosciences, Inc. · CIK 1426800 · Engraved from SEC EDGAR